Neuroprotective effects of acetylsalicylic acid in middle cerebral artery occlusion-induced brain ischemia in rats: Suppression of iNOS, HIF-1α, TNF-α, and active caspase-3 expression

Tsung Hao Chang, Chien Liang Liu, Kuang Hung Lin, Meng Nan Lin, George Hsiao, Joen Rong Sheu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Acetylsalicylic acid (ASA) is neuroprotective through various pharmacological action sites. The aim of this study was to examine the detailed mechanisms underlying the inhibitory effect of ASA in inflammatory and apoptotic responses induced by middle cerebral artery occlusion (MCAO) in rats. In this study, ASA significantly attenuated MCAO-induced focal cerebral ischemia in rats. Administration of ASA at 10-20 mg/kg showed marked reductions in infarct size compared with that of control rats. MCAO-induced focal cerebral ischemia was associated with increases in iNOS, HIF-1α, active caspase-3, and TNF-α mRNA expressions in ischemic regions. These expressions were markedly inhibited by treatment with ASA (20 mg/kg). In conclusion, the neuroprotective effect of ASA may mediate at least a portion of the inhibition of HIF-1α and TNF-α activations, followed by inhibition of apoptosis formation (active caspase-3) and inflammatory response (iNOS), resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury. Thus, ASA treatment may represent an ideal approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.

Original languageEnglish
Pages (from-to)793-799
Number of pages7
JournalPharmaceutical Biology
Volume46
Issue number10-11
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Middle Cerebral Artery Infarction
Neuroprotective Agents
Brain Ischemia
Caspase 3
Aspirin
Reperfusion Injury
Brain Injuries
Pharmacology
Apoptosis
Messenger RNA

Keywords

  • Acetylsalicylic acid
  • Caspase-3
  • HIF-1α
  • iNOS
  • Middle cerebral artery occlusion
  • TNF-α

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Pharmaceutical Science
  • Complementary and alternative medicine
  • Molecular Medicine

Cite this

Neuroprotective effects of acetylsalicylic acid in middle cerebral artery occlusion-induced brain ischemia in rats : Suppression of iNOS, HIF-1α, TNF-α, and active caspase-3 expression. / Chang, Tsung Hao; Liu, Chien Liang; Lin, Kuang Hung; Lin, Meng Nan; Hsiao, George; Sheu, Joen Rong.

In: Pharmaceutical Biology, Vol. 46, No. 10-11, 10.2008, p. 793-799.

Research output: Contribution to journalArticle

@article{f56cf9308f42466cadb460f0d4403e65,
title = "Neuroprotective effects of acetylsalicylic acid in middle cerebral artery occlusion-induced brain ischemia in rats: Suppression of iNOS, HIF-1α, TNF-α, and active caspase-3 expression",
abstract = "Acetylsalicylic acid (ASA) is neuroprotective through various pharmacological action sites. The aim of this study was to examine the detailed mechanisms underlying the inhibitory effect of ASA in inflammatory and apoptotic responses induced by middle cerebral artery occlusion (MCAO) in rats. In this study, ASA significantly attenuated MCAO-induced focal cerebral ischemia in rats. Administration of ASA at 10-20 mg/kg showed marked reductions in infarct size compared with that of control rats. MCAO-induced focal cerebral ischemia was associated with increases in iNOS, HIF-1α, active caspase-3, and TNF-α mRNA expressions in ischemic regions. These expressions were markedly inhibited by treatment with ASA (20 mg/kg). In conclusion, the neuroprotective effect of ASA may mediate at least a portion of the inhibition of HIF-1α and TNF-α activations, followed by inhibition of apoptosis formation (active caspase-3) and inflammatory response (iNOS), resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury. Thus, ASA treatment may represent an ideal approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.",
keywords = "Acetylsalicylic acid, Caspase-3, HIF-1α, iNOS, Middle cerebral artery occlusion, TNF-α",
author = "Chang, {Tsung Hao} and Liu, {Chien Liang} and Lin, {Kuang Hung} and Lin, {Meng Nan} and George Hsiao and Sheu, {Joen Rong}",
year = "2008",
month = "10",
doi = "10.1080/13880200802315659",
language = "English",
volume = "46",
pages = "793--799",
journal = "Pharmaceutical Biology",
issn = "1388-0209",
publisher = "Informa Healthcare",
number = "10-11",

}

TY - JOUR

T1 - Neuroprotective effects of acetylsalicylic acid in middle cerebral artery occlusion-induced brain ischemia in rats

T2 - Suppression of iNOS, HIF-1α, TNF-α, and active caspase-3 expression

AU - Chang, Tsung Hao

AU - Liu, Chien Liang

AU - Lin, Kuang Hung

AU - Lin, Meng Nan

AU - Hsiao, George

AU - Sheu, Joen Rong

PY - 2008/10

Y1 - 2008/10

N2 - Acetylsalicylic acid (ASA) is neuroprotective through various pharmacological action sites. The aim of this study was to examine the detailed mechanisms underlying the inhibitory effect of ASA in inflammatory and apoptotic responses induced by middle cerebral artery occlusion (MCAO) in rats. In this study, ASA significantly attenuated MCAO-induced focal cerebral ischemia in rats. Administration of ASA at 10-20 mg/kg showed marked reductions in infarct size compared with that of control rats. MCAO-induced focal cerebral ischemia was associated with increases in iNOS, HIF-1α, active caspase-3, and TNF-α mRNA expressions in ischemic regions. These expressions were markedly inhibited by treatment with ASA (20 mg/kg). In conclusion, the neuroprotective effect of ASA may mediate at least a portion of the inhibition of HIF-1α and TNF-α activations, followed by inhibition of apoptosis formation (active caspase-3) and inflammatory response (iNOS), resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury. Thus, ASA treatment may represent an ideal approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.

AB - Acetylsalicylic acid (ASA) is neuroprotective through various pharmacological action sites. The aim of this study was to examine the detailed mechanisms underlying the inhibitory effect of ASA in inflammatory and apoptotic responses induced by middle cerebral artery occlusion (MCAO) in rats. In this study, ASA significantly attenuated MCAO-induced focal cerebral ischemia in rats. Administration of ASA at 10-20 mg/kg showed marked reductions in infarct size compared with that of control rats. MCAO-induced focal cerebral ischemia was associated with increases in iNOS, HIF-1α, active caspase-3, and TNF-α mRNA expressions in ischemic regions. These expressions were markedly inhibited by treatment with ASA (20 mg/kg). In conclusion, the neuroprotective effect of ASA may mediate at least a portion of the inhibition of HIF-1α and TNF-α activations, followed by inhibition of apoptosis formation (active caspase-3) and inflammatory response (iNOS), resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury. Thus, ASA treatment may represent an ideal approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.

KW - Acetylsalicylic acid

KW - Caspase-3

KW - HIF-1α

KW - iNOS

KW - Middle cerebral artery occlusion

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=57649234182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649234182&partnerID=8YFLogxK

U2 - 10.1080/13880200802315659

DO - 10.1080/13880200802315659

M3 - Article

AN - SCOPUS:57649234182

VL - 46

SP - 793

EP - 799

JO - Pharmaceutical Biology

JF - Pharmaceutical Biology

SN - 1388-0209

IS - 10-11

ER -